Breaks Categories: News

FridayJun 29, 2018 12:40 pm

CannabisNewsBreaks – PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Closes Oversubscribed Private Placement

Health sciences company PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) this morning announced the closing of its oversubscribed non-brokered private placement financing, which was previously detailed on April 9, 2018. Per the update, a total of 130,779,750 units were issued under the financing at a price of $0.05 per unit for total gross proceeds of more than $6.5 million. “I am very pleased to announce this oversubscribed placement due to investor demand in our financing and see this as a strong endorsement of the quality of our research programs and management team,” Stephen Van Deventer, chairman, CEO and…

Continue Reading

FridayJun 29, 2018 9:33 am

CannabisNewsBreaks – The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) Adds Prem Virmani as Chair of Beverage Science and Research Division

Cannabis-focused research and development company The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) this morning announced that Prem Virmani, former senior vice president of global science and research for Cott Beverages, Inc., has been appointed Chair of TGOD’s Beverage Science and Research Division. Per the update, Virmani has over four decades of applicable industry experience, leading development in every major category, including the Sam’s Choice cola program for Walmart, the President’s Choice cola program for Loblaws and other major private label brands for Publix, Wegmans and Safeway. “I am delighted that Prem has joined the TGOD Leadership team,”…

Continue Reading

FridayJun 29, 2018 9:27 am

CannabisNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Files New Patent Application Following Breakthrough Discovery of Enhanced Drug Delivery to Brain Tissue

Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) this morning announced that it has filed a new patent application with the United States Patent and Trademark Office ("USPTO") for innovation in treatment options related to central nervous system disease or disorders including viral infection, cancer, neurodegenerative disorders, ADHD, anxiety, depression, OCD, schizophrenia, Alzheimer's, Huntington's, Parkinson's, neuropathic pain and more. The company reached a breakthrough discovery during recent laboratory testing that demonstrated significantly enhanced drug delivery to brain tissue. Evidence from the study showed unexpected effectiveness in crossing the blood-brain barrier ("BBB") which Lexaria is investigating more extensively, leading to the company's…

Continue Reading

WednesdayJun 27, 2018 9:37 am

CannabisNewsBreaks – The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) Enters European Market through JV Agreement in Denmark

Cannabis-focused research and development company The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) this morning announced its entry into a letter of intent for a 50/50 joint venture with Queen Genetics/Knud Jepsen A/S (“Knud Jepsen”), which is based in Hinnerup, Denmark. Per the update, the joint venture will initially consist of a 200,000 sq. ft. cannabis production facility located within Knud Jepsen’s 1.3 million sq. ft. state-of-the-art automated greenhouses in Denmark. Through this facility, TGOD will have an opportunity to increase its total organic funded capacity by roughly 25,000 kg. “We are very excited about entering the European…

Continue Reading

WednesdayJun 27, 2018 9:24 am

CannabisNewsBreaks – Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) to File IND, CTA with Health Authorities to Conduct Human Trials of PVT-005 in US and Canada

Pivot Pharmaceuticals (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) this morning announced that it will file an Investigational New Drug (“IND”) application with the U.S. Food and Drug Administration (“FDA”) and Clinical Trial Application (“CTA”) with Health Canada to begin human clinical trials of its pharmaceutical drug candidate for the treatment of Female Hypoactive Sexual Desire Disorder (“HSDD”), PVT-005. Pivot will employ its drug formulation and delivery platform technologies to develop a topical cream containing cannabinoids for perimenopausal, menopausal and post-menopausal women who have observed a decline in sexual desire and response. "In vitro results from our contract research laboratory indicated…

Continue Reading

TuesdayJun 26, 2018 10:00 am

CannabisNewsBreaks – Choom Holdings Inc. (CSE: CHOO) (OTCQB: CHOOF) Appoints New Director of Operations

British Columbia-based cannabis cultivation firm Choom Holdings Inc. (CSE: CHOO) (OTCQB: CHOOF) this morning announced its appointment of Kyp Rowe as its new director of operations. Per the update, Rowe will play a key role in Choom’s strategic development moving forward, leading the company’s premium craft cannabis cultivation strategy in support of its retail roll-out for the Canadian recreational market. “Bringing Kyp onboard significantly strengthens our team as we continue to prepare for when the Canadian recreational cannabis market commences on October 17, 2018,” Chris Bogart, president and CEO of Choom, stated in the news release. “Kyp brings over 20…

Continue Reading

FridayJun 22, 2018 9:52 am

CannabisNewsBreaks – The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTC: TGODF) Details Plans for Additional Cannabis Production Facility

Cannabis-focused research and development company The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) this morning announced its decision to add a 287,245 sq. ft. purpose-built facility on its Valleyfield property capable of producing 40,000 kg of premium organic cannabis. Per the update, this new facility will be dedicated to the company’s beverage division, and it will increase TGOD’s fully-funded capacity to 170,000 kg. TGOD intends to use excess cash raised in its IPO and subsequent bought deal financings to fund the construction of this new facility. “With the legalization of cannabis announced on June 20th, and Premier Justin…

Continue Reading

ThursdayJun 21, 2018 1:47 pm

CannabisNewsBreaks – Aphria Inc. (TSX: APH) (OTC: APHQF) Subsidiary Obtains First Cannabis Import License Issued by the Malta Medicines Authority

Aphria Inc. (TSX: APH) (OTC: APHQF) recently announced that its Malta-based subsidiary, ASG Pharma ("ASG"), has received the first import license for medical cannabis issued by the Malta Medicines Authority. The license enables ASG, a high-capacity EU GMP-certified lab, to import medical cannabis for analytical testing and research. The receipt of the license marks a significant milestone for the company, positioning ASG at the forefront of testing, research and development of medical cannabis in Europe. "Our EU GMP-certified lab in Malta will not only be a leading European center for R&D and testing, but also will provide a gateway to…

Continue Reading

ThursdayJun 21, 2018 9:47 am

CannabisNewsBreaks – Marijuana Company of America, Inc. (MCOA) and Global Hemp Group, Inc. (CSE: GHG) (FRA: GHG) (OTC: GBHPF) Post Update on New Brunswick Project

Marijuana Company of America Inc. (OTC: MCOA) and joint venture partner Global Hemp Group, Inc. (CSE: GHG) (FRANKFURT: GHG) (OTC: GBHPF) this morning posted an update on their hemp project in northeast New Brunswick. Per the update, the companies recently completed the planting of 125 acres of industrial hemp at the project location and were awarded a grant of $10,750 from the New Brunswick Department of Aquaculture, Agriculture and Fisheries (“DAAF”) to support demonstration projects it will undertake during the current cropping season. The grant will be used to study the impact of the European Corn Borer (“ECB”) on the…

Continue Reading

WednesdayJun 20, 2018 12:12 pm

CannabisNewsBreaks – The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTC: TGODF) Highlighted in Cannabis Industry Report by JGR Capital

Cannabis-focused research and development company The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) was recently highlighted alongside other cannabis-focused businesses in a Cannabis Industry Report for the week of June 11th by JGR Capital, a New York-based equity research firm. The report covered the company’s recent up-listing to the OTCQX® Best Market, which it began trading on under the symbol “TGODF” on June 14, 2018. Among other highlights, the report also covers Canopy Growth Corporation’s (TSX: WEED) (NYSE: CGC) offering of convertible senior notes; Maricann Group’s (CSE: MARI) (OTCQB: MRRCF) update regarding the acquirement of a cannabis license…

Continue Reading